Study: No single PSA level ensures safety from prostate cancer risk

July 12, 2005

Ian M. Thompson Jr., M.D., professor and chair of urology at the Health Science Center, is looking for a better test – or set of tests – to diagnose prostate cancer and to distinguish between cancers that will kill men if left untreated and those that will not threaten health and do not need treatment.





Pair of proteins said to be predictive of poor outcome in prostate cancer

August 10, 2004

Researchers at The University of Texas Health Science Center at San Antonio have identified two proteins that, when measured in tumors post-operatively, appear to represent a stronger marker for prostate cancer progression than the multiple risk factors used to predict death from coronary heart disease.